Dec 08, 2021 / 04:30PM GMT
Operator
Welcome to the SNN Network Canada Virtual Event. I'd like to introduce our next presenter, Michael McFadden, CEO of Alpha Cognition. Sir, the floor is yours.
Michael McFadden - Alpha Cognition Inc. - CEO & Director
Thank you so much. I'm very pleased to share an update on Alpha Cognition and some of the advancements in our current pipeline. I'll be using a forward-looking statement. Please consult the slide for the implications of those.
For those of you who aren't aware of Alpha Cognition, we are late-stage biopharmaceutical company. We're focused on neurodegenerative diseases.
We have a pipeline of three products. It's led by ALPHA-1062. That is a new treatment for mild-to-moderate Alzheimer's dementia. And we believe we formulated our product to be a best-in-class treatment, designed to optimize efficacious dose to minimize treatment-limiting side effects that occur with most of the agents approved today, and to also improve long-term outcomes that many patients with Alzheimer's suffer from.
The market is a very large market.
Alpha Cognition Inc at SNN Network Canada Virtual Event Transcript
Dec 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers